{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T08:46:39Z","timestamp":1785833199861,"version":"3.56.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T00:00:00Z","timestamp":1554249600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RF-2011-0234-7955"],"award-info":[{"award-number":["RF-2011-0234-7955"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s00415-019-09306-z","type":"journal-article","created":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T05:42:54Z","timestamp":1554356574000},"page":"1643-1648","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Serum and CSF neurofilament light chain levels in antibody-mediated encephalitis"],"prefix":"10.1007","volume":"266","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7806-3103","authenticated-orcid":false,"given":"Sara","family":"Mariotto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Gajofatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Zuliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Zoccarato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Gastaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Franciotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Cantalupo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Piardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Polo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Alberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Sartori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluigi","family":"Zanusso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Agr\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Demurtas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GianPietro","family":"Sechi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elia","family":"Sechi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Monaco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,3]]},"reference":[{"key":"9306_CR1","doi-asserted-by":"publisher","first-page":"e75091","DOI":"10.1371\/journal.pone.0075091","volume":"8","author":"J Gaiottino","year":"2013","unstructured":"Gaiottino J, Norgren N, Dobson R, Topping J, Nissim A, Malaspina A, Bestwick JP, Monsch AU, Regeniter A, Lindberg RL, Kappos L, Leppert D, Petzold A, Giovannoni G, Kuhle J (2013) Increased neurofilament light chain blood levels in neurodegenerative neurological diseases. PLoS One 8:e75091","journal-title":"PLoS One"},{"key":"9306_CR2","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1007\/s00415-017-8730-6","volume":"265","author":"D Rossi","year":"2018","unstructured":"Rossi D, Volanti P, Brambilla L, Colletti T, Spataro R, La Bella V (2018) CSF neurofilament proteins as diagnostic and prognostic biomarkers for amyotrophic lateral sclerosis. J Neurol 265:510\u2013521","journal-title":"J Neurol"},{"key":"9306_CR3","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/S1474-4422(17)30124-2","volume":"16","author":"LM Byrne","year":"2017","unstructured":"Byrne LM, Rodrigues FB, Blennow K, Durr A, Leavitt BR, Roos RAC, Scahill RI, Tabrizi SJ, Zetterberg H, Langbehn D, Wild EJ (2017) Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington\u2019s disease: a retrospective cohort analysis. Lancet Neurol 16:601\u2013609","journal-title":"Lancet Neurol"},{"key":"9306_CR4","doi-asserted-by":"publisher","first-page":"e1231","DOI":"10.1212\/WNL.0000000000005261","volume":"90","author":"LHH Meeter","year":"2018","unstructured":"Meeter LHH, Vijverberg EG, Del Campo M, Rozemuller AJM, Donker Kaat L, de Jong FJ, van der Flier WM, Teunissen CE, van Swieten JC, Pijnenburg YAL (2018) Clinical value of neurofilament and phospho-tau\/tau ratio in the frontotemporal dementia spectrum. Neurology 90:e1231\u2013e1239","journal-title":"Neurology"},{"key":"9306_CR5","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1212\/WNL.0000000000003154","volume":"87","author":"JD Rohrer","year":"2016","unstructured":"Rohrer JD, Woollacott IO, Dick KM, Brotherhood E, Gordon E, Fellows A, Toombs J, Druyeh R, Cardoso MJ, Ourselin S, Nicholas JM, Norgren N, Mead S, Andreasson U, Blennow K, Schott JM, Fox NC, Warren JD, Zetterberg H (2016) Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia. Neurology 87:1329\u20131336","journal-title":"Neurology"},{"key":"9306_CR6","doi-asserted-by":"publisher","DOI":"10.1111\/nan.12511","author":"B Gille","year":"2018","unstructured":"Gille B, De Schaepdryver M, Goossens J, Dedeene L, De Vocht J, Oldoni E, Goris A, Van Den Bosch L, Depreitere B, Claeys KG, Tournoy J, Van Damme P, Poesen K (2018) Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol. https:\/\/doi.org\/10.1111\/nan.12511","journal-title":"Neuropathol Appl Neurobiol"},{"key":"9306_CR7","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.parkreldis.2018.06.018","volume":"56","author":"L Donker Kaat","year":"2018","unstructured":"Donker Kaat L, Meeter LH, Chiu WZ, Melhem S, Boon AJW, Blennow K, Zetterberg H, van Swieten JC (2018) Serum neurofilament light chain in progressive supranuclear palsy. Parkinsonism Relat Disord 56:98\u2013101","journal-title":"Parkinsonism Relat Disord"},{"key":"9306_CR8","first-page":"205521731774309","volume":"3","author":"S Mariotto","year":"2017","unstructured":"Mariotto S, Farinazzo A, Monaco S, Gajofatto A, Zanusso G, Schanda K, Capra R, Mancinelli C, Bonora A, Bombardi R, Reindl M, Ferrari S (2017) Serum neurofilament light chain in NMOSD and related disorders: comparison according to aquaporin-4 and myelin oligodendrocyte glycoprotein antibodies status. Mult Scler J Exp Transl Clin 3:2055217317743098","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"9306_CR9","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1177\/1352458515623365","volume":"22","author":"J Kuhle","year":"2016","unstructured":"Kuhle J, Barro C, Disanto G, Mathias A, Soneson C, Bonnier G, Yaldizli \u00d6, Regeniter A, Derfuss T, Canales M, Schluep M, Du Pasquier R, Krueger G, Granziera C (2016) Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity. Mult Scler 22:1550\u20131559","journal-title":"Mult Scler"},{"key":"9306_CR10","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1212\/WNL.0000000000003653","volume":"88","author":"J Kuhle","year":"2017","unstructured":"Kuhle J, Nourbakhsh B, Grant D, Morant S, Barro C, Yaldizli \u00d6, Pelletier D, Giovannoni G, Waubant E, Gnanapavan S (2017) Serum neurofilament is associated with progression of brain atrophy and disability in early MS. Neurology 88:826\u2013831","journal-title":"Neurology"},{"key":"9306_CR11","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1212\/WNL.0000000000004683","volume":"89","author":"L Novakova","year":"2017","unstructured":"Novakova L, Zetterberg H, Sundstr\u00f6m P, Axelsson M, Khademi M, Gunnarsson M, Malmestr\u00f6m C, Svenningsson A, Olsson T, Piehl F, Blennow K, Lycke J (2017) Monitoring disease activity in multiple sclerosis using serum neurofilament light protein. Neurology 89:2230\u20132237","journal-title":"Neurology"},{"key":"9306_CR12","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1002\/ana.24954","volume":"81","author":"G Disanto","year":"2017","unstructured":"Disanto G, Barro C, Benkert P, Naegelin Y, Sch\u00e4delin S, Giardiello A, Zecca C, Blennow K, Zetterberg H, Leppert D, Kappos L, Gobbi C, Kuhle J, Swiss Multiple Sclerosis Cohort Study Group (2017) Serum neurofilament light: a biomarker of neuronal damage in multiple sclerosis. Ann Neurol 81:857\u2013870","journal-title":"Ann Neurol"},{"key":"9306_CR13","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1111\/ene.13274","volume":"24","author":"I H\u00e5kansson","year":"2017","unstructured":"H\u00e5kansson I, Tisell A, Cassel P, Blennow K, Zetterberg H, Lundberg P, Dahle C, Vrethem M, Ernerudh J (2017) Neurofilament light chain in cerebrospinal fluid and prediction of disease activity in clinically isolated syndrome and relapsing-remitting multiple sclerosis. Eur J Neurol 24:703\u2013712","journal-title":"Eur J Neurol"},{"key":"9306_CR14","doi-asserted-by":"publisher","DOI":"10.1177\/1352458518765666","author":"N Siller","year":"2018","unstructured":"Siller N, Kuhle J, Muthuraman M, Barro C, Uphaus T, Groppa S, Kappos L, Zipp F, Bittner S (2018) Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis. Mult Scler. https:\/\/doi.org\/10.1177\/1352458518765666","journal-title":"Mult Scler"},{"key":"9306_CR15","doi-asserted-by":"publisher","first-page":"e422","DOI":"10.1212\/NXI.0000000000000422","volume":"5","author":"KN Varhaug","year":"2017","unstructured":"Varhaug KN, Barro C, Bj\u00f8rnevik K, Myhr KM, Torkildsen \u00d8, Wergeland S, Bindoff LA, Kuhle J, Vedeler C (2017) Neurofilament light chain predicts disease activity in relapsing-remitting MS. Neurol Neuroimmunol Neuroinflamm 5:e422","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"9306_CR16","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1111\/ene.12942","volume":"23","author":"R Constantinescu","year":"2016","unstructured":"Constantinescu R, Kr\u00fdsl D, Bergquist F, Andr\u00e9n K, Malmestr\u00f6m C, Aszt\u00e9ly F, Axelsson M, Menachem EB, Blennow K, Rosengren L, Zetterberg H (2016) Cerebrospinal fluid markers of neuronal and glial cell damage to monitor disease activity and predict long-term outcome in patients with autoimmune encephalitis. Eur J Neurol 23:796\u2013806","journal-title":"Eur J Neurol"},{"key":"9306_CR17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jneuroim.2017.02.018","volume":"306","author":"R Constantinescu","year":"2017","unstructured":"Constantinescu R, Kr\u00fdsl D, Andr\u00e9n K, Aszt\u00e9ly F, Bergquist F, Zetterberg H, Andreasson U, Axelsson M, Menachem EB, Jons D, Mahamud U, Malmestr\u00f6m C, Rosengren L, Blennow K (2017) Cerebrospinal fluid markers of neuronal and glial cell damage in patients with autoimmune neurologic syndromes with and without underlying malignancies. J Neuroimmunol 306:25\u201330","journal-title":"J Neuroimmunol"},{"key":"9306_CR18","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1152\/physrev.00010.2016","volume":"97","author":"J Dalmau","year":"2017","unstructured":"Dalmau J, Geis C, Graus F (2017) Autoantibodies to synaptic receptors and neuronal cell surface proteins in autoimmune diseases of the central nervous system. Physiol Rev 97:839\u2013887","journal-title":"Physiol Rev"},{"key":"9306_CR19","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3389\/fimmu.2015.00206","volume":"6","author":"R H\u00f6ftberger","year":"2015","unstructured":"H\u00f6ftberger R (2015) Neuroimmunology: an expanding frontier in autoimmunity. Front Immunol 6:206","journal-title":"Front Immunol"},{"key":"9306_CR20","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1056\/NEJMra1708712","volume":"378","author":"J Dalmau","year":"2018","unstructured":"Dalmau J, Graus F (2018) Antibody-mediated encephalitis. N Engl J Med 378:840\u2013851","journal-title":"N Engl J Med"},{"key":"9306_CR21","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/ana.23932","volume":"74","author":"C Finke","year":"2013","unstructured":"Finke C, Kopp UA, Scheel M, Pech LM, Soemmer C, Schlichting J, Leypoldt F, Brandt AU, Wuerfel J, Probst C, Ploner CJ, Pr\u00fcss H, Paul F (2013) Functional and structural brain changes in anti-N-methyl-d-aspartate receptor encephalitis. Ann Neurol 74:284\u2013296","journal-title":"Ann Neurol"},{"key":"9306_CR22","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1093\/brain\/awq113","volume":"133","author":"SR Irani","year":"2010","unstructured":"Irani SR, Bera K, Waters P, Zuliani L, Maxwell S, Zandi MS, Friese MA, Galea I, Kullmann DM, Beeson D, Lang B, Bien CG, Vincent A (2010) N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 133:1655\u20131667","journal-title":"Brain"},{"key":"9306_CR23","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","volume":"7","author":"J Dalmau","year":"2008","unstructured":"Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, Dessain SK, Rosenfeld MR, Balice-Gordon R, Lynch DR (2008) Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 7:1091\u20131098","journal-title":"Lancet Neurol"},{"key":"9306_CR24","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","volume":"12","author":"MJ Titulaer","year":"2013","unstructured":"Titulaer MJ, McCracken L, Gabilondo I, Armangu\u00e9 T, Glaser C, Iizuka T, Honig LS, Benseler SM, Kawachi I, Martinez-Hernandez E, Aguilar E, Gresa-Arribas N, Ryan-Florance N, Torrents A, Saiz A, Rosenfeld MR, Balice-Gordon R, Graus F, Dalmau J (2013) Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 12:157\u2013165","journal-title":"Lancet Neurol"},{"key":"9306_CR25","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1093\/brain\/aws082","volume":"135","author":"CG Bien","year":"2012","unstructured":"Bien CG, Vincent A, Barnett MH, Becker AJ, Bl\u00fcmcke I, Graus F, Jellinger KA, Reuss DE, Ribalta T, Schlegel J, Sutton I, Lassmann H, Bauer J (2012) Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis. Brain 135:1622\u20131638","journal-title":"Brain"},{"key":"9306_CR26","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s00401-009-0582-4","volume":"118","author":"E T\u00fcz\u00fcn","year":"2009","unstructured":"T\u00fcz\u00fcn E, Zhou L, Baehring JM, Bannykh S, Rosenfeld MR, Dalmau J (2009) Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma. Acta Neuropathol 118:737\u2013743","journal-title":"Acta Neuropathol"},{"key":"9306_CR27","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1093\/brain\/awy154","volume":"141","author":"C Barro","year":"2018","unstructured":"Barro C, Benkert P, Disanto G, Tsagkas C, Amann M, Naegelin Y, Leppert D, Gobbi C, Granziera C, Yaldizli \u00d6, Michalak Z, Wuerfel J, Kappos L, Parmar K, Kuhle J (2018) Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis. Brain 141:2382\u20132391","journal-title":"Brain"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09306-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-019-09306-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09306-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T15:53:50Z","timestamp":1721145230000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-019-09306-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,3]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["9306"],"URL":"https:\/\/doi.org\/10.1007\/s00415-019-09306-z","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,3]]},"assertion":[{"value":"27 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Sa.Ma. was sponsored by Merck for attending a scientific meeting. AG received research support funding from Merck. Sa.Mo. received honoraria from Biogen. S.F. was sponsored by Shire for attending a scientific meeting. The other authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All human studies have been performed in accordance with the ethical standards laid down in the 1964 declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics standards"}},{"value":"We collected consented to diagnostic procedures and biological sample storage at the referring laboratory for research use from all patients or legal representatives.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}